PMGC Holdings Inc

Aktienanalyse zu PMGC Holdings Inc (ELAB)

$2.706

+0.047 (+1.72%)Zum Schluss

Loading chart…
Hoch
2.760
Eröffnung
2.760
Volumengewichteter Durchschnittskurs
2.72
Volumen
1.37K
Marktkap.
—
Tief
2.706
Umsatz
3.73K
EV/EBITDA, TTM
0.00

PMGC Holdings Inc. is a diversified holding company. Its operating companies include Northstrive Biosciences Inc., PMGC Capital LLC, Pacific Sun Packaging, Inc., ELAB Opportunity Holdings LLC, SVM Machining, Inc., NorthStrive Defense Tech LLC and A&B Aerospace, Inc. Northstrive Biosciences Inc. is a biopharmaceutical company focusing on development and acquisition of aesthetic medicines and therapeutic products. PMGC Capital LLC is a multi-strategy investment firm focused on direct investments, strategic lending, and acquiring undervalued companies and assets across diverse markets. Pacific Sun Packaging, Inc. is a specialty packaging provider focused on high-precision, component-level packaging solutions for the electronics and information technology hardware industries. NorthStrive Defense Tech LLC is focused on defense technology, including drone technology, autonomous systems, and next-generation unmanned defense solutions.

pmgcholdings.com

KI-Analyse of PMGC Holdings Inc (ELAB)

Verkaufen

Given the current price of 2.71 USD and a year-to-date change of -99.21%, ELEVAI Labs Inc is not a good buy right now. The stock has shown a very low RSI of 25.085, indicating it is oversold, but the overall trend is negative with a 5-day change of -2.32% and a staggering 99.81% decline over the past year. The main risk is the negative net income of -4,967,259 USD in Q1 2026, which raises concerns about the company's financial stability.

Bewertungskennzahlen

Das aktuelle erwartete KGV von PMGC Holdings Inc (ELAB) beträgt 0.00, verglichen mit dem 5-Jahres-Durchschnitt von 0.00.

Erwartetes KGV

Stark unterbewertet
5J-Durchschnitt P/E
0.00
Aktuelles P/E
0.00
Überbewertet
0.00
Unterbewertet
0.00

Erwartetes EV/EBITDA

Stark unterbewertet
5J-Durchschnitt EV/EBITDA
0.00
Aktuelles EV/EBITDA
0.00
Überbewertet
0.00
Unterbewertet
0.00

Erwartetes KUV

Stark unterbewertet
5J-Durchschnitt P/S
0.00
Aktuelles P/S
0.00
Überbewertet
0.00
Unterbewertet
0.00

Alphio-AI-Kursszenarien für ELAB

Szenariopreise sind das letzte monatliche Prognoseband des laufenden Jahres. Die Wahrscheinlichkeiten sind feste Modellgewichte (25 / 50 / 25), keine Garantien.

B

Bullisch

Bullisch · 25%ELAB

$2.60

Szenariopreis

B

Basis

Basis · 50%ELAB

$2.11

Szenariopreis

B

Bärisch

Bärisch · 25%ELAB

$1.76

Szenariopreis

Event-Zeitleiste

2026-10-08 (ET)

10:30:00

PMGC Holdings Registers NorthStrive DBA Name

2026-10-01 (ET)

08:30:00

PMGC Holdings Sponsors NorthStrive Acquisition Corp I.

2026-09-29 (ET)

08:00:00

PMGC Holdings Subsidiary Signs Statement of Work with Charles River Laboratories

2026-08-26 (ET)

09:00:00

PMGC Terminates Letter of Intent to Acquire Arizona Company

2026-08-25 (ET)

08:00:00

PMGC Enters Strategic Partnership with Orbit2Orbit

News

ELAB FAQ – beantwortet von Alphio AI

PMGC Holdings Inc. is a diversified holding company. Its operating companies include Northstrive Biosciences Inc., PMGC Capital LLC, Pacific Sun Packaging, Inc., ELAB Opportunity Holdings LLC, SVM Machining, Inc., NorthStrive Defense Tech LLC and A&B Aerospace, Inc. Northstrive Biosciences Inc. is a biopharmaceutical company focusing on development and acquisition of aesthetic medicines and therapeutic products. PMGC Capital LLC is a multi-strategy investment firm focused on direct investments, strategic lending, and acquiring undervalued companies and assets across diverse markets. Pacific Sun Packaging, Inc. is a specialty packaging provider focused on high-precision, component-level packaging solutions for the electronics and information technology hardware industries. NorthStrive Defense Tech LLC is focused on defense technology, including drone technology, autonomous systems, and next-generation unmanned defense solutions. It operates in the Basic Materials sector.

Given the current price of 2.71 USD and a year-to-date change of -99.21%, ELEVAI Labs Inc is not a good buy right now. The stock has shown a very low RSI of 25.085, indicating it is oversold, but the overall trend is negative with a 5-day change of -2.32% and a staggering 99.81% decline over the past year. The main risk is the negative net income of -4,967,259 USD in Q1 2026, which raises concerns about the company's financial stability.

Community

Mehr ↗

Noch keine Beiträge

Registriere dich oder melde dich an, um mitzudiskutieren

Diese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.

Jetzt handeln